NM_001145809.2:c.5469+16C>T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001145809.2(MYH14):c.5469+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 1,542,138 control chromosomes in the GnomAD database, including 424,673 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.66 ( 35484 hom., cov: 33)
Exomes 𝑓: 0.74 ( 389189 hom. )
Consequence
MYH14
NM_001145809.2 intron
NM_001145809.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.41
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-50293703-C-T is Benign according to our data. Variant chr19-50293703-C-T is described in ClinVar as [Benign]. Clinvar id is 257578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50293703-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH14 | NM_001145809.2 | c.5469+16C>T | intron_variant | Intron 39 of 42 | ENST00000642316.2 | NP_001139281.1 | ||
MYH14 | NM_001077186.2 | c.5370+16C>T | intron_variant | Intron 38 of 41 | NP_001070654.1 | |||
MYH14 | NM_024729.4 | c.5346+16C>T | intron_variant | Intron 37 of 40 | NP_079005.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.661 AC: 100501AN: 152014Hom.: 35464 Cov.: 33
GnomAD3 genomes
AF:
AC:
100501
AN:
152014
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.754 AC: 149415AN: 198216Hom.: 57800 AF XY: 0.757 AC XY: 79877AN XY: 105494
GnomAD3 exomes
AF:
AC:
149415
AN:
198216
Hom.:
AF XY:
AC XY:
79877
AN XY:
105494
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.745 AC: 1035465AN: 1390006Hom.: 389189 Cov.: 41 AF XY: 0.746 AC XY: 509743AN XY: 683016
GnomAD4 exome
AF:
AC:
1035465
AN:
1390006
Hom.:
Cov.:
41
AF XY:
AC XY:
509743
AN XY:
683016
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.661 AC: 100560AN: 152132Hom.: 35484 Cov.: 33 AF XY: 0.669 AC XY: 49765AN XY: 74368
GnomAD4 genome
AF:
AC:
100560
AN:
152132
Hom.:
Cov.:
33
AF XY:
AC XY:
49765
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2912
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jun 22, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Autosomal dominant nonsyndromic hearing loss 4A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at